Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Completed

Conditions studied: Lung Cancer

In brief

RATIONALE: Studying samples of tumor tissue and blood in the laboratory from patients with cancer may help doctors learn more about changes that occur in genetic material (DNA and RNA) and may also identify protein expression patterns related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study evaluates changes in DNA, RNA, and proteins with the goal of predicting response to treatment in patients with lung cancer.

Key facts

Study ID

NCT00897650

Run by

Vanderbilt-Ingram Cancer Center

People needed

204

Starts

2005-12-01

Expected to finish

2017-07-01

Last updated by the study team

2017-07-19

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of suspected lung cancer or lung cancer

You may not qualify if…

• Inability to undergo therapy

Where it is running

• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.